BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29393495)

  • 1. miR-195 inhibits cell proliferation and angiogenesis in human prostate cancer by downregulating PRR11 expression.
    Cai C; He H; Duan X; Wu W; Mai Z; Zhang T; Fan J; Deng T; Zhong W; Liu Y; Zhong W; Zeng G
    Oncol Rep; 2018 Apr; 39(4):1658-1670. PubMed ID: 29393495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
    Huang Y; Ni R; Wang J; Liu Y
    Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.
    Cai C; Chen QB; Han ZD; Zhang YQ; He HC; Chen JH; Chen YR; Yang SB; Wu YD; Zeng YR; Qin GQ; Liang YX; Dai QS; Jiang FN; Wu SL; Zeng GH; Zhong WD; Wu CL
    Clin Cancer Res; 2015 Nov; 21(21):4922-34. PubMed ID: 26080838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-130b/TNF-α/NF-κB/VEGFA loop inhibits prostate cancer angiogenesis.
    Mu HQ; He YH; Wang SB; Yang S; Wang YJ; Nan CJ; Bao YF; Xie QP; Chen YH
    Clin Transl Oncol; 2020 Jan; 22(1):111-121. PubMed ID: 31667686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The miR-203/SNAI2 axis regulates prostate tumor growth, migration, angiogenesis and stemness potentially by modulating GSK-3β/β-CATENIN signal pathway.
    Tian X; Tao F; Zhang B; Dong JT; Zhang Z
    IUBMB Life; 2018 Mar; 70(3):224-236. PubMed ID: 29389061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12.
    Xue D; Lu H; Xu HY; Zhou CX; He XZ
    J Cell Mol Med; 2018 Jun; 22(6):3223-3237. PubMed ID: 29633510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tumor suppressor miR-642a-5p targets Wilms Tumor 1 gene and cell-cycle progression in prostate cancer.
    Beveridge DJ; Richardson KL; Epis MR; Brown RAM; Stuart LM; Woo AJ; Leedman PJ
    Sci Rep; 2021 Sep; 11(1):18003. PubMed ID: 34504167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.
    Bai T; Liu Y; Li B
    IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-Suppressive Function of miR-30d-5p in Prostate Cancer Cell Proliferation and Migration by Targeting NT5E.
    Song Y; Song C; Yang S
    Cancer Biother Radiopharm; 2018 Jun; 33(5):203-211. PubMed ID: 29916747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA LINC00968 reduces cell proliferation and migration and angiogenesis in breast cancer through up-regulation of PROX1 by reducing hsa-miR-423-5p.
    Sun X; Huang T; Zhang C; Zhang S; Wang Y; Zhang Q; Liu Z
    Cell Cycle; 2019 Aug; 18(16):1908-1924. PubMed ID: 31213129
    [No Abstract]   [Full Text] [Related]  

  • 11. MicroRNA-26b-5p suppresses the proliferation of tongue squamous cell carcinoma via targeting proline rich 11 (PRR11).
    Yi L; Liu Y; Xu A; Li S; Zhang H; Peng M; Li Z; Ren H; Dai J; Luo C; Xiao Y; Zhou X; Long Y
    Bioengineered; 2021 Dec; 12(1):5830-5838. PubMed ID: 34488538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-15b-5p facilitates the tumorigenicity by targeting RECK and predicts tumour recurrence in prostate cancer.
    Chen R; Sheng L; Zhang HJ; Ji M; Qian WQ
    J Cell Mol Med; 2018 Mar; 22(3):1855-1863. PubMed ID: 29363862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Noncoding RNA SOX2-OT Knockdown Inhibits Proliferation and Metastasis of Prostate Cancer Cells Through Modulating the miR-452-5p/HMGB3 Axis and Inactivating Wnt/β-Catenin Pathway.
    Song X; Wang H; Wu J; Sun Y
    Cancer Biother Radiopharm; 2020 Nov; 35(9):682-695. PubMed ID: 32407168
    [No Abstract]   [Full Text] [Related]  

  • 14. The putative tumour suppressor miR-1-3p modulates prostate cancer cell aggressiveness by repressing E2F5 and PFTK1.
    Li SM; Wu HL; Yu X; Tang K; Wang SG; Ye ZQ; Hu J
    J Exp Clin Cancer Res; 2018 Sep; 37(1):219. PubMed ID: 30185212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.
    Lin ZY; Chen G; Zhang YQ; He HC; Liang YX; Ye JH; Liang YK; Mo RJ; Lu JM; Zhuo YJ; Zheng Y; Jiang FN; Han ZD; Wu SL; Zhong WD; Wu CL
    Mol Cancer; 2017 Feb; 16(1):48. PubMed ID: 28241827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reciprocal regulation of PCGEM1 and miR-145 promote proliferation of LNCaP prostate cancer cells.
    He JH; Zhang JZ; Han ZP; Wang L; Lv YB; Li YG
    J Exp Clin Cancer Res; 2014 Sep; 33(1):72. PubMed ID: 25200485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-144-3p Induces Cell Cycle Arrest and Apoptosis in Pancreatic Cancer Cells by Targeting Proline-Rich Protein 11 Expression via the Mitogen-Activated Protein Kinase Signaling Pathway.
    Li J; Sun P; Yue Z; Zhang D; You K; Wang J
    DNA Cell Biol; 2017 Aug; 36(8):619-626. PubMed ID: 28574724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of miR-449a-caused PrLZ overexpression promotes prostate cancer metastasis.
    Chen W; Liu Y; Chen H; Ning H; Ding K
    Int J Oncol; 2017 Aug; 51(2):435-444. PubMed ID: 28627667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells.
    Jones DZ; Schmidt ML; Suman S; Hobbing KR; Barve SS; Gobejishvili L; Brock G; Klinge CM; Rai SN; Park J; Clark GJ; Agarwal R; Kidd LR
    BMC Cancer; 2018 Apr; 18(1):421. PubMed ID: 29653561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.
    Kiener M; Chen L; Krebs M; Grosjean J; Klima I; Kalogirou C; Riedmiller H; Kneitz B; Thalmann GN; Snaar-Jagalska E; Spahn M; Kruithof-de Julio M; Zoni E
    BMC Cancer; 2019 Jun; 19(1):627. PubMed ID: 31238903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.